Evidence map›Paper›PMID 41378103›Full record

ArticleBiochemistry and biophysics reports2025

Systematic analysis of the expression profiles and prognostic values of the FAM72 family in liver cancer.

Weihao Kong, Long Teng, Kangjie Zhang, Yajun Zou, Xingyu Wang, Jianlin Zhang

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weihao KongDepartment of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Long TengDepartment of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Kangjie ZhangWest China Clinical Medical College, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Yajun ZouDepartment of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xingyu WangDepartment of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jianlin ZhangDepartment of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Family with sequence similarity 72 (FAM72) plays a crucial role in the functions of neural stem cells, specifically in promoting the self-renewal capabilities of neural progenitor cells. The FAM72 family members FAM72A-D have been shown to play a role in tumorigenicity. However, their expression and prognostic significance in liver cancer remain unknown. In this study, we used bioinformatics analyses to assess the expression and prognostic relevance of FAM72A-D in liver cancer. The expression levels of FAM72A-D were markedly elevated in liver cancer tissues compared with normal tissues. FAM72A-D expression correlated with advanced clinical stage, high histological grade, and unfavorable prognosis in patients with liver cancer. Single-cell RNA sequencing results suggested that FAM72A-D are predominantly present in proliferative T cells. We examined genetic alterations in FAM72A-D and found that gene mutations were linked to low overall survival rates in patients with liver cancer. We further developed a robust FAM72 gene signature to predict the prognosis of patients with liver cancer, and the gene signature was associated with immune infiltration. Collectively, these findings indicate the involvement of the FAM72 family in liver tumorigenesis and suggest its potential utility as a biomarker for adverse prognostic outcomes.

Indexed as

BioinformaticsFAM72 familyImmune infiltrationLiver cancerPrognosis

Identifiers

PMID41378103
PMCPMC12686641

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.